V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20025918 | 20011018 | 1.74 | 81 | Adjuvant (A) | 2015-09-12 | 2015-09-18 | FEC + DOCETAXEL | 2 | N | 20091383 | FEC + DOCETAXEL |
| 20025919 | 20011019 | 1.55 | null | Neo-adjuvant (N) | 2018-10-22 | 2018-11-05 | FEC + DOCETAXEL | N | N | 20091391 | FEC + DOCETAXEL |
| 20025920 | 20071461 | 1.68 | null | Adjuvant (A) | 2016-09-13 | 2016-09-14 | FEC + DOCETAXEL | 02 | N | 20091392 | FEC + DOCETAXEL |
| 20025921 | 20011020 | 1.61 | 85 | Adjuvant (A) | 2013-09-08 | 2013-09-10 | FEC + DOCETAXEL | 02 | null | 20091396 | FEC + DOCETAXEL |
| 20025922 | 20011021 | null | 78.4 | Adjuvant (A) | 2016-10-04 | 2016-10-07 | FEC + DOCETAXEL | 02 | N | 20091398 | FEC + DOCETAXEL |
| 20025923 | 20011021 | 1.61 | 64.6 | Adjuvant (A) | 2017-05-17 | 2017-05-24 | FEC + DOCETAXEL | 02 | N | 20091398 | FEC + DOCETAXEL |
| 20025924 | 20011022 | 1.66 | 67.9 | Adjuvant (A) | null | 2015-07-25 | FEC + DOCETAXEL | N | N | 20091411 | FEC + DOCETAXEL |
| 20025925 | 20011022 | 1.58 | 78.8 | Neo-adjuvant (N) | 2013-06-28 | 2013-06-28 | FEC + DOCETAXEL | N | N | 20091411 | FEC + DOCETAXEL |
| 20025926 | 20011023 | 1.61 | 77.8 | Adjuvant (A) | 2016-09-23 | 2016-09-24 | FEC + DOCETAXEL | 2 | N | 20091420 | FEC + DOCETAXEL |
| 20025927 | 20011024 | 1.72 | 83.6 | Adjuvant (A) | 2013-11-04 | 2013-11-10 | FEC + DOCETAXEL | 02 | N | 20091422 | FEC + DOCETAXEL |
| 20025928 | 20011024 | null | 60 | Neo-adjuvant (N) | 2015-06-07 | 2015-06-23 | FEC + DOCETAXEL | N | N | 20091422 | FEC + DOCETAXEL |
| 20025929 | 20011025 | 1.76 | 60 | Adjuvant (A) | 2017-05-19 | 2017-05-22 | FEC 100 + DOCETAXEL | 02 | N | 20091428 | FEC + DOCETAXEL |
| 20025930 | 20071465 | 1.77 | 64 | Neo-adjuvant (N) | 2014-03-17 | 2014-03-18 | FEC + DOCETAXEL | 2 | N | 20091430 | FEC + DOCETAXEL |
| 20025931 | 20011026 | null | 53.7 | Adjuvant (A) | 2013-09-03 | 2013-09-06 | FEC + DOCETAXEL | 02 | N | 20091432 | FEC + DOCETAXEL |
| 20025932 | 20011026 | 1.65 | 73 | Neo-adjuvant (N) | 2015-06-10 | 2015-06-23 | FEC + DOCETAXEL | 02 | N | 20091432 | FEC + DOCETAXEL |
| 20025933 | 20011027 | 1.71 | 66 | Curative (C) | 2018-02-23 | 2018-02-26 | FEC + DOCETAXEL | 02 | N | 20091434 | FEC + DOCETAXEL |
| 20025934 | 20011028 | null | 64 | null | null | 2014-08-06 | FEC + DOCETAXEL | null | null | 20091435 | FEC + DOCETAXEL |
| 20025935 | 20011028 | 1.57 | 58.7 | Adjuvant (A) | 2017-04-21 | 2017-05-14 | FEC + DOCETAXEL | N | N | 20091435 | FEC + DOCETAXEL |
| 20025936 | 20011029 | 1.61 | 71.45 | Adjuvant (A) | 2016-10-22 | 2016-10-23 | FEC + DOCETAXEL | 02 | N | 20091446 | FEC + DOCETAXEL |
| 20025937 | 20011030 | null | 114 | Adjuvant (A) | 2017-06-03 | 2017-06-27 | FEC 100 + DOCETAXEL | 2 | N | 20091447 | FEC + DOCETAXEL |
| 20025938 | 20011030 | 1.65 | 69.2 | Adjuvant (A) | 2014-11-08 | 2014-11-15 | FEC + DOCETAXEL | 02 | N | 20091447 | FEC + DOCETAXEL |
| 20025939 | 20011031 | null | null | Not known (9) | 2014-10-03 | 2014-10-20 | FEC 100 + DOCETAXEL | null | null | 20091450 | FEC + DOCETAXEL |
| 20025940 | 20011031 | 1.7 | 116.9 | Neo-adjuvant (N) | 2016-04-24 | 2016-04-27 | FEC + DOCETAXEL | 2 | N | 20091450 | FEC + DOCETAXEL |
| 20025941 | 20011032 | 0 | 112 | Adjuvant (A) | 2013-10-18 | 2013-10-25 | FEC + DOCETAXEL | 02 | N | 20091456 | FEC + DOCETAXEL |
| 20025942 | 20011033 | 1.63 | 65.7 | Curative (C) | 2013-10-02 | 2013-10-23 | FEC 100 + DOCETAXEL | 2 | N | 20091461 | FEC + DOCETAXEL |
| 20025943 | 20011033 | 1.73 | 56 | Neo-adjuvant (N) | 2013-09-24 | 2013-10-08 | FEC + DOCETAXEL | N | N | 20091461 | FEC + DOCETAXEL |
| 20025944 | 20011033 | 1.64 | 69.3 | Adjuvant (A) | 2015-12-30 | 2016-01-12 | FEC 100 + DOCETAXEL | N | N | 20091461 | FEC + DOCETAXEL |
| 20025945 | 20011033 | 1.64 | 51.6 | Not known (9) | 2018-01-10 | 2018-01-10 | FEC + DOCETAXEL | 02 | N | 20091461 | FEC + DOCETAXEL |
| 20025946 | 20011034 | 1.6 | 54.5 | Curative (C) | 2013-10-11 | 2013-10-27 | FEC + DOCETAXEL | 02 | Y | 20091476 | FEC + DOCETAXEL |
| 20025947 | 20011034 | 1.62 | 84.6 | Adjuvant (A) | 2015-11-08 | 2015-11-08 | FEC + DOCETAXEL | 02 | N | 20091476 | FEC + DOCETAXEL |
| 20025948 | 20011035 | 1.68 | 78.8 | Adjuvant (A) | 2017-03-28 | 2017-04-12 | FEC + DOCETAXEL | 02 | N | 20091494 | FEC + DOCETAXEL |
| 20025949 | 20011036 | 1.8 | null | Adjuvant (A) | 2015-10-23 | 2016-01-15 | FEC 100 + DOCETAXEL | 02 | N | 20091500 | FEC + DOCETAXEL |
| 20025950 | 20071472 | null | 77.6 | Neo-adjuvant (N) | 2016-08-29 | 2016-09-15 | FEC + DOCETAXEL | 99 | null | 20091506 | FEC + DOCETAXEL |
| 20025951 | 20071472 | null | null | Adjuvant (A) | null | 2014-07-25 | FEC 100 + DOCETAXEL | null | null | 20091506 | FEC + DOCETAXEL |
| 20025952 | 20071472 | 1.58 | 85 | Adjuvant (A) | 2014-03-13 | 2014-04-09 | FEC + DOCETAXEL | N | N | 20091506 | FEC + DOCETAXEL |
| 20025953 | 20071472 | 1.56 | 70 | Adjuvant (A) | 2018-03-22 | 2018-04-19 | FEC + DOCETAXEL | N | null | 20091506 | FEC + DOCETAXEL |
| 20025954 | 20011037 | 1.82 | 52.5 | Adjuvant (A) | 2015-08-02 | 2015-08-09 | FEC + DOCETAXEL | N | N | 20091517 | FEC + DOCETAXEL |
| 20025955 | 20011037 | 1.61 | 80.5 | Neo-adjuvant (N) | null | 2017-08-30 | FEC + DOCETAXEL | N | N | 20091517 | FEC + DOCETAXEL |
| 20025956 | 20011038 | 1.68 | 80.8 | Adjuvant (A) | 2017-06-23 | 2017-07-04 | FEC + DOCETAXEL | 2 | N | 20091524 | FEC + DOCETAXEL |
| 20025957 | 20071474 | 1.58 | 91 | Neo-adjuvant (N) | 2017-12-03 | 2017-12-04 | FEC + DOCETAXEL | 2 | N | 20091528 | FEC + DOCETAXEL |
| 20025958 | 20011039 | 1.56 | 112 | Adjuvant (A) | 2016-07-10 | 2016-07-11 | FEC + DOCETAXEL | 2 | N | 20091529 | FEC + DOCETAXEL |
| 20025959 | 20011040 | 1.65 | 75.5 | Neo-adjuvant (N) | 2015-08-11 | 2015-08-20 | FEC + DOCETAXEL | 02 | N | 20091530 | FEC + DOCETAXEL |
| 20025960 | 20011040 | 1.73 | 98 | Neo-adjuvant (N) | 2015-09-28 | 2015-10-02 | FEC + DOCETAXEL | 2 | N | 20091530 | FEC + DOCETAXEL |
| 20025961 | 20011040 | 1.52 | 65.6 | Neo-adjuvant (N) | 2015-10-29 | 2015-11-12 | FEC + DOCETAXEL | N | N | 20091530 | FEC + DOCETAXEL |
| 20025962 | 20011041 | null | 66 | Adjuvant (A) | 2013-12-11 | 2013-12-27 | FEC 100 + DOCETAXEL | null | null | 20091534 | FEC + DOCETAXEL |
| 20025963 | 20071476 | 1.71 | 73.1 | Adjuvant (A) | 2014-03-15 | 2014-03-24 | FEC + DOCETAXEL | 2 | N | 20091538 | FEC + DOCETAXEL |
| 20025964 | 20011042 | 1.56 | 98.7 | Adjuvant (A) | 2013-04-10 | 2013-05-01 | FEC + DOCETAXEL | 2 | N | 20091544 | FEC + DOCETAXEL |
| 20025965 | 20011043 | 1.78 | 76.6 | Adjuvant (A) | 2016-06-26 | 2016-07-23 | FEC + DOCETAXEL | 2 | N | 20091547 | FEC + DOCETAXEL |
| 20025966 | 20011043 | 1.64 | 92 | Not known (9) | 2015-05-24 | 2015-05-31 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 2 | N | 20091547 | FEC + DOCETAXEL |
| 20025967 | 20011043 | 1.62 | 68.8 | Adjuvant (A) | 2015-05-21 | 2015-06-13 | FEC + DOCETAXEL | 02 | null | 20091547 | FEC + DOCETAXEL |